The Community Guide

- gsearch

Search Results

Narrow Results:

2020 8

Coronavirus Infections/prevention & control 6
Coronavirus Infections/prevention & Control 2
COVID-19 3
COVID-19 Vaccines 5
GRADE Approach 2
Pandemics 8
Vaccination 8
Viral Vaccines 8

Presentation 8

Conference Publications 8

1 - 8 of 8 Results

Refine Results

Refine Results:

Use of Pfizer-BioNTech COVID-19 vaccine : clinical considerations

CITE Title : Use of Pfizer-BioNTech COVID-19 vaccine : clinical considerations Personal Author(s) : Mbaeyi, Sarah A. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 12, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105436 Mbaeyi, Sarah A. (2020). Use of Pfizer-BioNTech COVID-19 vaccine : clinical considerations. 2000211(020103). Mbaeyi, Sarah A. "Use of Pfizer-BioNTech COVID-19 vaccine : clinical considerations" 2000211, no. 020103 (2020) Mbaeyi, Sarah A. "Use of Pfizer-BioNTech COVID-19 vaccine : clinical considerations" vol. 2000211, no. 020103, 2020 Export RIS Citation Information.

:

Mbaeyi, Sarah A.

December 12, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-03-Mbaeyi-508.pdf
Work Group interpretation and next steps

CITE Title : Work Group interpretation and next steps Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 11, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105433 Oliver, Sara E. (2020). Work Group interpretation and next steps. 2000211(010104). Oliver, Sara E. "Work Group interpretation and next steps" 2000211, no. 010104 (2020) Oliver, Sara E. "Work Group interpretation and next steps" vol. 2000211, no. 010104, 2020 Export RIS Citation Information.

:

Oliver, Sara E.

December 11, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-04-Oliver-508.pdf
ACIP COVID-19 Vaccines Work Group

CITE Title : ACIP COVID-19 Vaccines Work Group Personal Author(s) : Bell, Beth P. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 11, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105430 Bell, Beth P. (2020). ACIP COVID-19 Vaccines Work Group. 2000211(0100101). Bell, Beth P. "ACIP COVID-19 Vaccines Work Group" 2000211, no. 0100101 (2020) Bell, Beth P. "ACIP COVID-19 Vaccines Work Group" vol. 2000211, no. 0100101, 2020 Export RIS Citation Information.

:

Bell, Beth P.

December 11, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-01-Bell-508.pdf
ACIP COVID-19 Vaccines Work Group

CITE Title : ACIP COVID-19 Vaccines Work Group Personal Author(s) : Bell, Beth P. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 12, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105434 Bell, Beth P. (2020). ACIP COVID-19 Vaccines Work Group. 2000211(020101). Bell, Beth P. "ACIP COVID-19 Vaccines Work Group" 2000211, no. 020101 (2020) Bell, Beth P. "ACIP COVID-19 Vaccines Work Group" vol. 2000211, no. 020101, 2020 Export RIS Citation Information.

:

Bell, Beth P.

December 12, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-01-Bell-508.pdf
Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine

CITE Title : Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine Personal Author(s) : Gargano, Julia W. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 11, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105432 Gargano, Julia W. (2020). Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine. 2000211(010103). Gargano, Julia W. "Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine" 2000211, no. 010103 (2020) Gargano, Julia W. "Grading of recommendations, assessment, development, and evaluation (GRADE) : Pfizer BioNTech COVID-19 vaccine" vol. 2000211, no. 010103, 2020 Export RIS Citation Information.

:

Gargano, Julia W.

December 11, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-03-Gargano.pdf
BNT162b2 vaccine candidate against COVID-19

CITE Title : BNT162b2 vaccine candidate against COVID-19 Personal Author(s) : Gruber, William Corporate Authors(s) : Pfizer Ltd;BioNTech SE; Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 11, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105431 Gruber, William (2020). BNT162b2 vaccine candidate against COVID-19. 2000211(010102). Gruber, William "BNT162b2 vaccine candidate against COVID-19" 2000211, no. 010102 (2020) Gruber, William "BNT162b2 vaccine candidate against COVID-19" vol. 2000211, no. 010102, 2020 Export RIS Citation Information.

:

Gruber, William

December 11, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-02-Gruber-508.pdf
EtR framework : Pfizer-BioNTech COVID-19 vaccine

CITE Title : EtR framework : Pfizer-BioNTech COVID-19 vaccine Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 12, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105435 Oliver, Sara E. (2020). EtR framework : Pfizer-BioNTech COVID-19 vaccine. 2000211(020102). Oliver, Sara E. "EtR framework : Pfizer-BioNTech COVID-19 vaccine" 2000211, no. 020102 (2020) Oliver, Sara E. "EtR framework : Pfizer-BioNTech COVID-19 vaccine" vol. 2000211, no. 020102, 2020 Export RIS Citation Information.

:

Oliver, Sara E.

December 12, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-02-Oliver-508.pdf
Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?

CITE Title : Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization? Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2020 December 11-12, 2020 : Atlanta, GA) Published Date : December 12, 2020 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105437 United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. (2020). Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?. 2000211(020104). United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. "Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?" 2000211, no. 020104 (2020) United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. "Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?" vol. 2000211, no. 020104, 2020 Export RIS Citation Information.

:

United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.

December 12, 2020 | ACIP meeting COVID-19 Vaccines

:

COVID-04-VOTE-508.pdf